Investigating how ethnicity affects T cell responses and signaling in prostate cancer
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
This study is looking at why African American and European American men might have different experiences with prostate cancer, focusing on how their bodies' immune responses and genetics play a role, so we can find better treatments for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10983805 on NIH RePORTER |
What this research studies
This research focuses on understanding the differences in prostate cancer outcomes between African American and European American men. It examines how genetic and biological factors, particularly T cell responses and signaling pathways, contribute to these disparities. By developing patient-derived tumor organoids and analyzing immune responses, the study aims to uncover mechanisms that influence treatment effectiveness. The research utilizes advanced techniques to explore the role of specific proteins and immune cells in prostate cancer progression and response to therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American men diagnosed with prostate cancer.
Not a fit: Patients who are not African American or do not have prostate cancer may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for prostate cancer in African American men.
How similar studies have performed: Previous studies have shown promising results in understanding racial disparities in cancer treatment responses, indicating that this research builds on established findings.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Zi, Xiaolin — University of California-Irvine
- Study coordinator: Zi, Xiaolin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.